Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a Canadian biotech firm focused on autoimmune diseases, presents an intriguing opportunity for investors seeking exposure in the healthcare sector. With a market capitalization of..
Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) stands as a prominent player in the medical care facilities sector, offering a diversified range of home healthcare services across the United States. With..
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is making waves in the biotechnology sector with its innovative focus on cellular metabolism. Headquartered in Cambridge, Massachusetts, Agios is renowned for its development of..
Janux Therapeutics, Inc. (NASDAQ: JANX), a promising player in the biotechnology sector, is captivating investor attention with its innovative approach to cancer treatment. With a market capitalization of $827.63 million,..
Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, is currently capturing investor attention with its promising growth trajectory and significant potential upside. Based in Burlingame, California, Innoviva..
Opko Health, Inc. (NASDAQ: OPK), a key player in the healthcare sector, is stirring interest among investors with its compelling growth potential. Despite its recent challenges, the diagnostics and pharmaceuticals..
GoodRx Holdings, Inc. (NASDAQ: GDRX) represents a unique player in the healthcare sector, particularly within the Health Information Services industry. As a company providing consumers with the ability to compare..
MannKind Corporation (NASDAQ: MNKD) has carved a niche in the healthcare sector, with a focus on developing and commercializing therapeutic products for endocrine and orphan lung diseases. Based in Danbury,..
Dynavax Technologies Corporation (NASDAQ: DVAX) is a prominent player in the healthcare sector, specifically within the drug manufacturing industry, focusing on specialty and generic products. Based in the United States,..
Omnicell, Inc. (NASDAQ: OMCL) is a noteworthy player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $2.32 billion, Omnicell is making strides..
Investors interested in Harrow, Inc. (NASDAQ: HROW) will find plenty to be optimistic about as the company positions itself as a formidable player in the healthcare sector. Specializing in the..
Pulse Biosciences, Inc (NASDAQ: PLSE) is capturing the attention of investors with its innovative approach to bioelectric medicine. Operating within the healthcare sector and specializing in medical instruments and supplies,..
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is making waves in the biotechnology sector, driven by its innovative approach to tackling diseases associated with dysregulated aldosterone. With a market capitalization of $2.59..
Artivion, Inc. (NASDAQ: AORT), a prominent player in the healthcare sector, specifically within the medical devices industry, is catching the attention of investors with a compelling potential upside of 19.18%...
UFP Technologies, Inc. (NASDAQ: UFPT), a key player in the healthcare sector specializing in medical devices, has caught the attention of investors with a promising potential upside of 26.48%. With..
Phreesia, Inc. (PHR), a prominent player in the healthcare sector, offers investors a compelling proposition with its integrated SaaS-based software and payment platform tailored for the healthcare industry across the..
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) stands out as a promising player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $1.91..
Biohaven Ltd. (BHVN) has been catching the eye of investors in the biotech sector, not least because of its substantial 51.7% potential upside according to analyst targets. With a market..
MiMedx Group, Inc. (NASDAQ: MDXG) stands at a pivotal point for investors seeking to capitalize on the burgeoning biotech sector. Specializing in the development and distribution of placental tissue allografts,..
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to drug discovery. Leveraging a blend of biology, chemistry, automation,..
